Yüksel Ürün/X
May 5, 2025, 12:30
Yüksel Ürün: Longitudinal ctDNA profiling in mCRPC reveals How Tumors Evolve
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article on X:
“Tracking resistance in real time:
Longitudinal ctDNA profiling in mCRPC reveals how tumors evolve.
- Greater subclonal shifts seen with AR-targeted therapy vs taxanes.
- Emerging clones enriched for PI3K-AKT alterations.”
Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy.
Authors: Yuehui Zhao, Naveen Ramesh, Ping Xu, Emi Sei, Min Hu, Shanshan Bai, Patricia Troncoso, Ana M. Aparicio, Christopher J. Logothetis, Paul G. Corn, Nicholas E. Navin, Amado J. Zurita.
You can read the Full Article on Journal of American Association of Cancer Research.
More posts featuring Yüksel Ürün.
Amado J Zurita
Ana M. Aparicio
Ankara University School of Medicine
cancer
Christopher J Logothetis
Circulating tumor DNA
Emi Sei
fight against cancer
Global fight against cancer
Longitudinal ctDNA profiling
mCRPC
MedOnc
metastatic prostate cancer
Min Hu
Naveen Ramesh
Nicholas E. Navin
OncoDaily
Oncology
Patricia Troncoso
Paul G Corn
PI3K-AKT
Ping Xu
prostate cancer
Shanshan Bai
targeted therapy
taxanes
Yuehui Zhao
Yüksel Ürün
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 5, 2025, 14:43
May 5, 2025, 13:42
May 5, 2025, 13:40
May 5, 2025, 13:18